Viewing Study NCT04547166


Ignite Creation Date: 2025-12-24 @ 4:42 PM
Ignite Modification Date: 2025-12-29 @ 11:57 PM
Study NCT ID: NCT04547166
Status: RECRUITING
Last Update Posted: 2024-10-17
First Post: 2020-09-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Study to Evaluate Efficacy and Safety of Serplulimab(HLX10) Combined With Bevacizumab(HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)
Sponsor: Shanghai Henlius Biotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module